These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2249366)

  • 1. Pathogenesis of anti-Ro/SS-A autoantibody-associated cutaneous lupus erythematosus.
    Sontheimer RD; McCauliffe DP
    Dermatol Clin; 1990 Oct; 8(4):751-8. PubMed ID: 2249366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Ro antibodies and neonatal lupus.
    Petri M; Watson R; Hochberg MC
    Rheum Dis Clin North Am; 1989 May; 15(2):335-60. PubMed ID: 2657894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the Ro/SS-A autoimmune response.
    Sontheimer RD; Lieu TS; McCauliffe DP
    Semin Dermatol; 1991 Sep; 10(3):199-205. PubMed ID: 1931569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus.
    Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA
    J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review.
    Sontheimer RD
    Photochem Photobiol; 1996 May; 63(5):583-94. PubMed ID: 8628749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous paraneoplastic syndrome as an immunologic phenomenon exemplified by paraneoplastic subacute cutaneous lupus erythematosus].
    Trüeb RF; Trüeb RM
    Praxis (Bern 1994); 1999 Oct; 88(44):1803-10. PubMed ID: 10584550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus.
    Furukawa F
    Histol Histopathol; 1999 Apr; 14(2):627-33. PubMed ID: 10212823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
    Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
    Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and redistribution of the Ro autoantigen in Balb/c mouse like in subacute cutaneous lupus erythematosus.
    Herrera-Esparza R; Villalobos R; Bollain-Y-Goytia JJ; Ramírez-Sandoval R; Sánchez-Rodriguez SH; Pacheco-Tovar G; Avalos-Diaz E
    Clin Dev Immunol; 2006; 13(2-4):163-6. PubMed ID: 17162359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.
    Sontheimer RD
    Autoimmun Rev; 2005 Jun; 4(5):253-63. PubMed ID: 15990071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
    Böckle BC; Stanarevic G; Sepp NT
    J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
    Ruzicka T; Bieber T; Meurer M
    Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole.
    McCourt C; Somerville J; McKenna K
    Eur J Dermatol; 2010; 20(6):860-1. PubMed ID: 20974555
    [No Abstract]   [Full Text] [Related]  

  • 14. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.
    Furukawa F; Itoh T; Wakita H; Yagi H; Tokura Y; Norris DA; Takigawa M
    Clin Exp Immunol; 1999 Oct; 118(1):164-70. PubMed ID: 10540174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of the interpretation of autoantibodies: apropos of a case with anti-Ro antibodies during pregnancy].
    Zufferey C; Truscello A; Pécoud A
    Schweiz Med Wochenschr; 1990 Jan; 120(1-2):27-9. PubMed ID: 2296708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recognition of human 60-kDa Ro ribonucleoprotein particles by antibodies associated with cutaneous lupus and neonatal lupus.
    Lee LA; Alvarez K; Gross T; Harley JB
    J Invest Dermatol; 1996 Aug; 107(2):225-8. PubMed ID: 8757767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal lupus syndrome associated with ribonucleoprotein antibodies.
    Heelan K; Watson R; Collins SM
    Pediatr Dermatol; 2013; 30(4):416-23. PubMed ID: 23432184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of subacute cutaneous lupus erythematosus.
    Stavropoulos PG; Goules AV; Avgerinou G; Katsambas AD
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1281-9. PubMed ID: 18540991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.